Strados Labs

How can you build confidence in a groundbreaking device? By making the regulatory journey crystal clear. 💡 Strados Labs is transforming respiratory care with their innovative RESP® Biosensor, a wearable technology that tracks critical symptoms like cough and wheeze for conditions like COPD and asthma. However, when it came to working with clinical trial teams, they faced a challenge: How to effectively communicate the extensive validation and regulatory clearances of their device. 📔 That’s where DiMe’s The Playbook: Digital Clinical Measures came in. By leveraging The Playbook, Strados Labs clearly demonstrated the regulatory framework and clinical validation behind RESP® Biosensor. As a result, clinical trial teams gained the confidence needed to integrate this cutting-edge technology into their studies, accelerating the path to better patient outcomes. Discover how Strados Labs bridged the communication gap and set the stage for greater adoption of their RESP® technology. 💪 As Strados Labs continues to advance respiratory health through innovative solutions, The Playbook will remain a crucial resource, guiding them in their mission to enhance patient outcomes and improve the quality of life for those living with chronic respiratory diseases. 📖 Read the DiMe deep dive here: https://bit.ly/4erFv9u

We’re pleased to share insights from Dr. Henry Schmidt, MD, Principal Investigator of our recent pediatric asthma study in collaboration with Ann & Robert H. Lurie Children's Hospital of Chicago. This study assessed the performance and usability of the RESP® Biosensor in children with asthma, a condition affecting over 5 million children annually and a leading cause of ED visits. Previously used only with adults, the RESP Biosensor shows significant potential in enhancing pediatric asthma management. Key findings revealed the biosensor's sensitivity in detecting wheezing, receiving overwhelmingly positive feedback from both patients and families. Participants valued its ease of use, expressing optimism for better at-home wheeze detection and access to care. Dr. Schmidt highlights that continuous lung sound monitoring could greatly improve pediatric asthma care by providing clinicians with objective data at home and in the hospital. This technology allows for earlier assessments, paving the way for timely interventions and improved patient outcomes. Read the full interview here: https://bit.ly/480cQWx #pediatricasthma #respiratoryhealth #medicalinnovation #digitalhealth #clinicalresearch

October is National Healthy Lung Month, a reminder to prioritize lung health and raise awareness about protecting our lungs from neglect, bronchitis, mold, pollution, and smoking. If you experience a persistent cough, chest tightness, wheezing, or shortness of breath, especially during physical activity, don’t ignore these warning signs. They could indicate serious lung issues, and a doctor’s visit can help catch problems early.   Take advantage of community resources this October to manage lung conditions, quit smoking, and breathe easier. Learn more: https://bit.ly/4duh3Df   #healthylungmonth #lunghealth #makeeverybreathcount

Our team will be attending the 21st BioPharma Clinical Trials Nexus Conference in just two weeks from October 22-23 in Somerset, NJ! https://lnkd.in/d8J_rmEN The event gathers top clinical trial decision-makers and solution providers to address challenges and trends in clinical operations, patient-centricity, clinical outsourcing, and digital innovation. Nick Delmonico, Shane Krauss and Devan Parson, MBA are looking forward to connecting and engaging with life sciences and clinical trial leaders! #clinicaltrials #biopharma #digitalhealth #patientcentricity #NexusClinical

Strados Labs, a medical technology company focused on improving patients' lives with respiratory disease through innovative technology, created the RESP Biosensor, a wearable device that allows clinicians to remotely detect changes in patient symptom and enable the real-world monitoring of lung health. However, as Strados Labs engaged with sponsor organizations' clinical trial teams, they faced a recurring challenge: effectively communicating the regulatory clearances and validation work behind their RESP Biosensor. 📔 To overcome this challenge, Strados Labs turned to DiMe’s The Playbook: Digital Clinical Measures to help bridge the communication gap. The Playbook served as the perfect tool to clarify critical points such as regulatory clearances, the validity of their measures, and the differentiation between data validation and regulatory clearance, as well as refine Strados Labs’ communication of regulatory requirements. “The Playbook has been an invaluable resource for us in conversations with clinical trial teams at life sciences organizations,” said Nick Delmonico, CEO of Strados Labs. Incorporating The Playbook into its communications strategy was vital for Strados Labs to effectively frame conversations around its technology and allowed them to build trust and confidence with sponsor organizations while ensuring they fully understood the FDA framework for evaluating wearable sensors and digital measures. 👉 Read more about Strados Labs’ success here: https://bit.ly/4erFv9u

Our RESP® technology offers more than precise cough measurements—it delivers a complete view of respiratory health. In this video, our CEO Nick Delmonico explains how tracking cough productivity, intensity, and spasms, along with treatment plans and other symptoms like wheezing and shortness of breath, provides a detailed clinical picture. #cough #coughmonitoring #respiratoryhealth #StradosLabs

The Centers for Disease Control and Prevention’s 2024-2025 respiratory virus season outlook predicts that peak hospitalizations for COVID-19, influenza, and RSV will likely be similar to or lower than last season, with an 80% probability. These insights highlight the need for continued monitoring and preventive measures. At Strados Labs, we’re dedicated to advancing remote respiratory monitoring solutions that support patients and clinicians during this critical season. For more details on the CDC’s outlook, check out this overview from TechTarget: https://bit.ly/3MZfjXz #respiratoryhealth #COVID19 #RSV #fluseason #digitalhealth

How can we make Decentralized Clinical Trials (DCTs) more accessible for older adults? With nearly 70% of all prescription medicines consumed by those 65 and over, it’s crucial to include them in clinical research. DCTs are gaining traction, offering home visits and mobile research to reduce the burden on patients and caregivers. However, digital literacy remains a challenge for many seniors, highlighting the need for a balanced approach between technology and human interaction. Learn more from Clinical Trials Arena: https://bit.ly/3A9D3p2 For respiratory trials involving seniors, our RESP® Biosensor is an ideal solution. Compared to bulkier alternatives, it reduces subject and site burden. Wireless and discreet, it allows patients to behave naturally, capturing authentic symptom data that mirrors real-life conditions. #decentralizedclinicaltrials #DCTs #clinicaltrials #clinicalresearch #seniors

The recent evidence on the burden of cough in IPF and other ILDs underscores the need for consistent, objective measurement. Cough remains a disruptive symptom that greatly impacts patients' quality of life. https://bit.ly/4gGytPB At Strados Labs, we see an opportunity to use standardized tools like the RESP Biosensor to provide objective, direct data on cough severity, which could serve as endpoints in IPF studies to better evaluate treatment efficacy and disease progression.   #IPF #ILD #cough #coughmonitoring #respiratoryhealth

The RESP® Biosensor was designed with both clinicians and patients in mind. Patients can easily apply the small, discreet device to their chest, sync it with an app, and start recording breath sounds with just a tap. This allows care teams to access lung sound data remotely, ensuring continuous monitoring without disrupting daily life. Its low-profile design enhances patient comfort and promotes adherence, capturing data in natural settings. Hear from Devan Parson, MBA, our Clinical Operations Manager, on how she utilized RESP in a clinical trial for #asthma and #COPD patients: https://lnkd.in/gwzbHXN4 #patientcentricity #respiratorycare #decentralizedclinicaltrials #clinicalresearch